Doxorubicin Hydrochloride Injection, Suspension, Liposomal
Product Images NDC 75907-364

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 75907-364). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Doxorubicin-10ml-carton-drl (Doxorubicin 10ml Carton Drl)

Doxorubicin-10ml-carton-drl (Doxorubicin 10ml Carton Drl)
This is a medical product label for Doxorubicin Hydrochloride liposome injection manufactured by Dr. Reddy's Laboratories. The medication is used for intravenous infusion and contains important information such as composition, dosing instructions, storage conditions, and precautions. It is important to follow the instructions provided, including dilution with 5% Dextrose Injection, USP before use. The medication should be refrigerated and unused portions discarded. Additional details about the formulation and manufacturer's contact information are also included in the label.*
FDA Label Image

Doxorubicin-10ml-vial-drl (Doxorubicin 10ml Vial Drl)

Doxorubicin-10ml-vial-drl (Doxorubicin 10ml Vial Drl)
This is a description of a pharmaceutical product called DOXOrubicin Hydrochloride Liposome Injection. It is a cytotoxic medication provided in a 10 mL single-dose vial with a concentration of 20 mg/10 mL (2 mg/mL). It is intended for intravenous infusion only after dilution, and it is crucial not to substitute it for other medications. The storage recommendation is to refrigerate between 2° to 8°C (36° to 46°F), and it must not be frozen. The product is manufactured for Dr. Reddy's Laboratories in the USA and is a product of Germany. It includes a lot number and expiration date (not specified in the text). The packaging contains prescribing information, and the dosage should be followed based on that guidance.*
FDA Label Image

Doxorubicin-25ml-carton-drl (Doxorubicin 25ml Carton Drl)

Doxorubicin-25ml-carton-drl (Doxorubicin 25ml Carton Drl)
FDA Label Image

Doxorubicin-25ml-vial-drl (Doxorubicin 25ml Vial Drl)

Doxorubicin-25ml-vial-drl (Doxorubicin 25ml Vial Drl)
FDA Label Image

Doxorubicin-figure-1 (Doxorubicin Figure 1)

Doxorubicin-figure-1 (Doxorubicin Figure 1)
This text contains information related to a research study comparing the treatment of Doxorubicin HCI+Bortezomib and Bortezomib. It includes a p-value < 0.0001, Hazard Ratio (HR) of 0.5 with a 95% confidence interval of 0.43 to 0.71. The data also presents a time frame in months and the number of subjects at risk in each treatment group.*
FDA Label Image

Doxorubicin-hspe (Doxorubicin Hspe)

Doxorubicin-hspe (Doxorubicin Hspe)
FDA Label Image

Doxorubicin-mpeg-dspe (Doxorubicin Mpeg Dspe)

Doxorubicin-mpeg-dspe (Doxorubicin Mpeg Dspe)
FDA Label Image

Doxorubicin-pegylated-liposome (Doxorubicin Pegylated Liposome)

Doxorubicin-pegylated-liposome (Doxorubicin Pegylated Liposome)
This description indicates the presence of MPEG-DSPE coating on an aqueous core containing doxorubicin HCI, enveloped by a liposomal bilayer. The use of MPEG-DSPE coating in this drug delivery system suggests enhanced stability and functionality, while the presence of doxorubicin HCI and liposomal bilayer indicates potential for targeted drug delivery applications.*
FDA Label Image

Doxorubicin-structure. (Doxorubicin Structure)

Doxorubicin-structure. (Doxorubicin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.